SAFETY AND EFFICACY OF MAHAGNIWATI IN THE MANAGEMENT OF NON PROLIFERATIVE DIABETIC RETINOPATHY (NPDR): AN OPEN LABELLED, RANDOMIZED, CONTROLLED CLINICAL TRIAL

2021 ◽  
pp. 1
Author(s):  
Amrut Salunke ◽  
Hema Kolpe ◽  
Amit Nakanekar
Sign in / Sign up

Export Citation Format

Share Document